PapersPMID:33169240
Efficacy of Citicoline as a Neuroprotector in children with post cardiac arrest: a randomized controlled clinical trial.
- findings
- 2
- compound
- 1
- endpoints
- 2
- Study, every finding
- RCT · 6 weeks
- Dose studied, every finding
- 10 mg/kg every 12 hours for 6 weeks
- Population, every finding
- Children surviving in-hospital cardiac arrest in paediatric and surgical ICUs; both arms received supportive measures
What moved
How to read these marks →“Seizure frequency and duration, mortality, PICU and hospital stay significantly decreased in citicholine group compared to the control group.”
- Decreases all-cause mortality
very limited
- Decreases hospital length of stay
very limited
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- children surviving in-hospital cardiac arrest, pediatric intensive care units and surgical ICU, Tanta university hospital
- Participants
- 80
- Comparator
- no treatment
- Duration
- 42 days
- Endpoints measured
- 8